Literature DB >> 19138330

Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis.

N Putzki1, A Pfriem, V Limmroth, O Yaldizli, B Tettenborn, H C Diener, Z Katsarava.   

Abstract

BACKGROUND: Prevalence rates of headache in multiple sclerosis (MS) patients varied widely in recent studies. This study aimed to investigate the 1 year prevalence of headache in MS compared with the general population.
METHODS: Population-based case-control study in Germany.
RESULTS: We included 491 patients with definite MS (68% female, mean age 45.3 years, 63.7% relapsing remitting MS, mean Expanded Disability Status Scale (EDSS) 3.2, 106 treated with interferon-beta, 53 with glatiramer acetate, 271 untreated) and 447 age and gender matched controls. Headache was diagnosed with a validated questionnaire according to the International Headache Society Criteria. Headache prevalence was 56.2% (tension type headache 37.2%, migraine 24.6%). Headache prevalence rates did not differ from controls. Headache was not associated with disability or treatment. Trigeminal neuralgia was found in 6.3% of MS cases.
CONCLUSION: Results suggest that headache in MS patients reflects comorbidity in most conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19138330     DOI: 10.1111/j.1468-1331.2008.02406.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  35 in total

Review 1.  The radiologically isolated syndrome: take action when the unexpected is uncovered?

Authors:  Johann Sellner; Lucas Schirmer; Bernhard Hemmer; Mark Mühlau
Journal:  J Neurol       Date:  2010-05-26       Impact factor: 4.849

2.  Determinants of the severity of comorbid migraine in multiple sclerosis.

Authors:  Veronica Villani; Laura De Giglio; Giuliano Sette; Carlo Pozzilli; Marco Salvetti; Luca Prosperini
Journal:  Neurol Sci       Date:  2012-05-27       Impact factor: 3.307

3.  Headache in the course of multiple sclerosis: a prospective study.

Authors:  Marcel Gebhardt; Peter Kropp; Frank Hoffmann; Uwe K Zettl
Journal:  J Neural Transm (Vienna)       Date:  2018-11-30       Impact factor: 3.575

4.  Increased risk of multiple sclerosis among women with migraine in the Nurses' Health Study II.

Authors:  Ilya Kister; Kassandra L Munger; Joseph Herbert; Alberto Ascherio
Journal:  Mult Scler       Date:  2011-08-03       Impact factor: 6.312

5.  Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density.

Authors:  Janine Mikolajczak; Hanna Zimmermann; Ahmad Kheirkhah; Ella Maria Kadas; Timm Oberwahrenbrock; Rodrigo Muller; Aiai Ren; Joseph Kuchling; Holger Dietze; Harald Prüss; Friedemann Paul; Pedram Hamrah; Alexander U Brandt
Journal:  Mult Scler       Date:  2016-11-03       Impact factor: 6.312

6.  Are Periventricular Lesions Specific for Multiple Sclerosis?

Authors:  Gianna Casini; Mary Yurashevich; Rohini Vanga; Subasini Dash; Suhayl Dhib-Jalbut; Brian Gerhardstein; Matilde Inglese; Win Toe; Konstantin E Balashov
Journal:  J Neurol Neurophysiol       Date:  2013-05-03

7.  Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course.

Authors:  Ilya Kister; A B Caminero; T S Monteith; A Soliman; T E Bacon; J H Bacon; J T Kalina; M Inglese; J Herbert; R B Lipton
Journal:  J Headache Pain       Date:  2010-07-13       Impact factor: 7.277

Review 8.  Multiple sclerosis-related central pain disorders.

Authors:  Turo J Nurmikko; Sameer Gupta; Kate Maclver
Journal:  Curr Pain Headache Rep       Date:  2010-06

Review 9.  Tension-type headache and migraine in multiple sclerosis.

Authors:  Ilya Kister; Ana B Caminero; Joseph Herbert; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2010-12

10.  Dramatically changing rates and reasons for hospitalization in multiple sclerosis.

Authors:  Ruth Ann Marrie; Lawrence Elliott; James Marriott; Michael Cossoy; James Blanchard; Aruni Tennakoon; Nancy Yu
Journal:  Neurology       Date:  2014-08-01       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.